Outcome of Board Meeting

Q2FY27 results (unaudited): Consolidated: Revenue 76.1bn +23% y-y (61.9bn) EBITDA 11.9bn +29% y-y (9.2bn) EBITDA margin 15.6% (14.9%) +70 bps y-y PAT 6.3bn +32% y-y (4.8bn) H1FY27 results (unaudited): Consolidated: Revenue 145.5bn +22% y-y (119.2bn) EBITDA 22.7bn +29% y-y (17.6bn) EBITDA margin 15.6% (14.7%) +90 bps y-y PAT 12.1bn +33% y-y (9.1bn) Dividend: Not stated Commentary: Apollo Hospitals is progressing with its expansion program to add ~5,800 beds over the next five years, with new hospitals ramping up and a Gurugram facility on track for Q3 FY27 commissioning. Revenue growth was driven by robust volume increases in key specialties and international patient services grew 37% YoY in Q2 FY27.